Vaccine news: US and European stock markets all rose sharply; Dow rose 900 points

category:Finance
 Vaccine news: US and European stock markets all rose sharply; Dow rose 900 points


Financial stocks rallied, with JPMorgan Chase up 5.09%, Goldman Sachs up 5.72%, Citigroup up 8.92%, Morgan Stanley up 7.99%, Bank of America up 6.9%, Wells Fargo up 8.69% and Berkshire Hathaway up 3.96%.

In Europe, the main indexes closed up sharply. By the end of the day, the Stoxx 50 Index in Europe was up 5.05%, the FTSE 100 index in Britain was up 4.29%, the CAC40 index in France was up 5.60%, and the DAX30 index in Germany was up 5.16%.

In addition, the hope of global economic activity reviving may drive up crude oil demand. According to a report, Chinas crude oil demand basically recovered to the level before the outbreak. These good news helped the oil price jump to a two-month high, with US crude oil futures up 8.12%, London Brent crude oil futures up more than 7%, close to the $35 level.

Novel coronavirus pneumonia cases were released in Beijing, and the total number of new crown pneumonia cases was 4782539 and 317566 deaths were recorded as of 6 hours and 0 minutes in May 19th, according to the Johns Hopkins Universitys real-time statistics.

There are 1504386 new coronavirus infections in the United States, including 90194 deaths. Compared with the previous days 6:30 data, 19582 new confirmed cases and 795 new deaths were found in the United States. At present, there are 351371 cases of infection, including 28339 deaths, in New York State, which is the most seriously affected state. In addition, New Jersey, Illinois, Massachusetts, California, Pennsylvania, Michigan and other states also have more than 50000 cases of infection.

45 us new crown vaccine subjects produced antibodies, 8 produced neutralizing antibodies

In the evening of May 18, Beijing time, Moderna, an American pharmaceutical company and biotechnology company, announced early Monday morning (before the US stock market) that a new coronavirus vaccine of great concern to the company had produced antibodies against the new coronavirus in 45 participants in the early phase II human trial.

It is reported that Moderna vaccine contains a laboratory generated genetic code called messenger RNA or mRNA, which can tell human cells what antibodies to build.

Moderna said that two novel coronavirus pneumonia recipients had been tested for forty-third days after the second day vaccination. The researchers found that the level of the antibody produced by the 25 micrograms dose group was the same as that of the new crown pneumonia rehabilitation sera. In addition, the new coronavirus antibody produced by the participants in the 100 u03bc g dose group even significantly exceeded the antibody level in the rehabilitation patients.

In addition, Moderna said the vaccine also produced neutralizing antibodies against the new coronavirus in at least eight subjects. For example, diphtheria antitoxin can neutralize the biochemical action of the bacteria causing diphtheria to achieve the therapeutic effect. Experts believe that neutralizing antibodies are good for the prevention of new coronavirus infection.

Of the eight subjects, four received 25 micrograms of the vaccine, while the other four received 100 micrograms. Moderna said that after vaccination, the eight participants neutralizing antibody levels either reached or exceeded the level of serum antibody in the convalescent patients. However, the company added that there was no neutralizing antibody data for other participants.

Although this is the first phase of early data, it shows that even if only 25 micrograms of mrna-1273 vaccine are administered, it can produce an immune response in patients with new coronavirus infection, Modena CEO tal Zaks said in a statement

Combining the novel coronavirus pneumonia model previously developed successfully (i.e., injecting corresponding doses to produce the same level of neutralizing antibody and avoiding viral replication in the lung) these data confirm our belief that the mRNA-1273 vaccine has the ability to prevent new crown pneumonia and to determine the dose for critical trials. He added.

Stimulated by the news, Moderna soared nearly 40% before Mondays trading and then opened 29% higher. Moderna rose 19.96% to close.

In terms of anti new crown drugs, ridcivir, the anti crown virus drug of Gilead Science Co., Ltd., is likely to obtain the EUs conditional listing authorization in the next few days.

Powell: the Fed will keep interest rates close to zero until the US economy gets back on track

In a speech released ahead of Tuesdays Senate hearing, Federal Reserve Chairman Jerome Powell said the Fed was ready to use all its tools and keep its benchmark lending rate close to zero until the economy gets back on track.

Powell said people should not short the US economy and firmly played down the view that the US economy faced the second great depression. However, he is also careful not to expect a quick V-shaped rebound. The economy will recover. It could take a while, he said. It may be extended to the end of next year. We really dont know.

Powell also stressed that the Feds policy tools to support the economy are not exhausted.

There is still a lot we can do, and we will continue to do our best. However, I would say that we are far from running out of ammunition, he said, noting that the Federal Reserve can increase its emergency loan program and make monetary policy more supportive by providing forward-looking guidance and adjusting its asset purchase strategy.

Muddy water said in the report that at least 80% of users who learn from others are robots, and suspected that at least 80% of their income from learning from others is fake, or even more than 90%. As a result, the share price of the company fell by more than 16%.

Public reports show that in the past three months, learning from whom has been short for many times. On February 25, grizzly, a shorting agency, issued a shorting report, saying that when it applied to go public, it overestimated its profitability, there was a phenomenon of brushing the list, falsely increased the number of students, and called it the worst listed education enterprise to learn from.

On April 14, the shorting agency citron released a shorting report on who it learned from, saying that up to 70% of its revenue is fictitious and that stock trading should be suspended and investigated. To this question, learn from who quickly fought back in the early morning of the 15th, claiming that citrons short report has a lot of repetition of the previous bears short report, but has been clarified and proved by the management. Later, on the noon of April 15, a detailed explanation was issued to refute the short selling report of citron, saying that the report was full of subjective malice and generalizations, attempting to mislead investors and the public, so as to achieve the purpose of short selling for profit.

Since then, citron has twice issued a short report on who to learn from. After citron released its third short report, on May 8, Chen Xiangdong, the founder and CEO of whose school, responded that many investors had fed back that citrons report was really rotten, the so-called real hammer was really ugly, without any substantive evidence and rigorous quantitative analysis.

Trump claims to be taking hydroxychloroquine to prevent new crown

On May 18th, novel coronavirus pneumonia was taken by the US President Trump, who had been taking the drug for more than a week to prevent the infection of the new crown pneumonia. Hydroxychloroquine is a highly recommended drug by trump. However, up to now, there is no definite evidence that hydroxychloroquine can prevent and treat new coronavirus. A number of studies have shown that the drug is not only unable to prevent infection with the new coronavirus, but also may cause damage to the heart. The U.S. Food and drug administration has warned against using oxychloroquine outside hospitals and clinical trials. On April 23, trump spoke astonishingly at the White House outbreak briefing. Ive noticed that disinfectants kill the virus in a minute, and theres no way to inject disinfectant into the body and get it into the lungs, which has a huge impact on the lungs, and I think its interesting, he said As soon as this statement was made, it immediately caused a public outcry in the United States. Some experts said Trumps speech at the press conference was a misinformation, fearing that the public might take wrong actions and be hurt after hearing his suggestion. Source: responsible editor of Securities Times: Yang bin_nf4368

On April 23, trump spoke astonishingly at the White House outbreak briefing. Ive noticed that disinfectants kill the virus in a minute, and theres no way to inject disinfectant into the body and get it into the lungs, which has a huge impact on the lungs, and I think its interesting, he said As soon as this statement was made, it immediately caused a public outcry in the United States. Some experts said Trumps speech at the press conference was a misinformation, fearing that the public might take wrong actions and be hurt after hearing his suggestion.